{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:54:53Z","timestamp":1761101693155},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,4,20]],"date-time":"2004-04-20T00:00:00Z","timestamp":1082419200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1038\/sj.bjc.6601794","type":"journal-article","created":{"date-parts":[[2004,6,18]],"date-time":"2004-06-18T14:14:09Z","timestamp":1087568049000},"page":"1912-1919","source":"Crossref","is-referenced-by-count":9,"title":["Estimating the survival benefits gained from providing national cancer genetic services to women with a family history of breast cancer"],"prefix":"10.1038","volume":"90","author":[{"given":"G L","family":"Griffith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R T","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,4,20]]},"reference":[{"key":"BF6601794_CR1","first-page":"s361","volume":"5","author":"SE Brooks","year":"1999","unstructured":"Brooks SE (1999) Breast cancer: overview of current management considerations of economic impact. Am J Managed Care 5: s361\u2013s366","journal-title":"Am J Managed Care"},{"key":"BF6601794_CR2","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1136\/bmj.311.7020.1584","volume":"311","author":"H Campbell","year":"1995","unstructured":"Campbell H, Mackay J, Porteous M (1995) The future of breast and ovarian cancer clinics. BMJ 311: 1584\u20131585","journal-title":"BMJ"},{"key":"BF6601794_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","volume":"336","author":"F Couch","year":"1997","unstructured":"Couch F, De Shano M, Blackwood M, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber B (1997) BRCA1 mutation in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336: 1409\u20131415","journal-title":"N Engl J Med"},{"key":"BF6601794_CR4","volume-title":"The Genetic Basis of Human Cancer","author":"FJ Couch","year":"1998","unstructured":"Couch FJ, Weber BL (1998) Breast cancer. In: Vogelstein B, Kinzler KW (eds) The Genetic Basis of Human Cancer. New York: McGraw-Hill"},{"key":"BF6601794_CR5","first-page":"678","volume":"52","author":"DF Easton","year":"1993","unstructured":"Easton DF, Bishop DT, Ford DF, Crockford GP (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52: 678\u2013701","journal-title":"Am J Hum Genet"},{"key":"BF6601794_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ajmg.1320560305","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT (1995) The Breast Cancer Linkage Consortium. Breast and Ovarian cancer incidence in BRCA1 \u2013 mutation carriers. Am J Hum Genet 56: 265\u2013271","journal-title":"Am J Hum Genet"},{"key":"BF6601794_CR7","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1038\/bjc.1998.366","volume":"77","author":"DM Eccles","year":"1998","unstructured":"Eccles DM, Englefield P, Soulby MA, Campbell IG (1998) BRCA1 mutations in Southern England. Br J Cancer 77: 2199\u20132203","journal-title":"Br J Cancer"},{"key":"BF6601794_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/bmj.313.7057.572","volume":"313","author":"R Eeles","year":"1996","unstructured":"Eeles R (1996) Testing for the breast cancer predisposition gene BRCA1. BMJ 313: 572","journal-title":"BMJ"},{"key":"BF6601794_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"M Buxton","year":"1990","unstructured":"EuroQol Group ( Buxton M, O'Hanlon M, Pekurinen M) (1990) EuroQol: a new facility for the measurement of health related quality of life. Health Policy 16: 199\u2013208","journal-title":"Health Policy"},{"key":"BF6601794_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/bmj.308.6922.183","volume":"308","author":"DGR Evans","year":"1994","unstructured":"Evans DGR, Fentiman IS, McPherson K, Asbury D, Ponder BAJ, Howell A (1994) Fortnightly review: familial breast cancer. BMJ 308: 183\u2013187","journal-title":"BMJ"},{"key":"BF6601794_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"342","author":"D Ford","year":"1994","unstructured":"Ford D, Easton, DF, Bishop DT, Norad SA, Goldgar DE (Breast Cancer Link Consortium) (1994) Risk of cancer in BRCA1-mutation carriers. Lancet 342: 692\u2013695","journal-title":"Lancet"},{"key":"BF6601794_CR12","first-page":"1457","volume":"57","author":"D Ford","year":"1995","unstructured":"Ford D, Easton DR, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457\u20131462","journal-title":"Am J Hum Genet"},{"key":"BF6601794_CR13","first-page":"283","volume":"5","author":"VR Grann","year":"1999","unstructured":"Grann VR, Jacobson JS, Sundarajan V, Albert SM, Troxel AB, Neugut AI (1999b) The quality of life associated with prophylactic treatment for women with BRCA1\/2 mutations. Cancer J Sci Am 5: 283\u2013292","journal-title":"Cancer J Sci Am"},{"key":"BF6601794_CR14","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","volume":"20","author":"VR Grann","year":"2002","unstructured":"Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI (2002) Effect of prevention strategies on survival and quality adjusted survival of women with BRCA1\/2 mutations: an updated decision analysis. J Clin Oncol 20: 2520\u20132529","journal-title":"J Clin Oncol"},{"key":"BF6601794_CR15","first-page":"13","volume":"6","author":"VR Grann","year":"2000","unstructured":"Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, Neugut AI (2000) Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1\/2-positive women: a decision analysis. Cancer J Sci Am 6: 13\u201320","journal-title":"Cancer J Sci Am"},{"key":"BF6601794_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1200\/JCO.1998.16.3.979","volume":"16","author":"VR Grann","year":"1998","unstructured":"Grann VR, Panageas KS, Whang W, Antman KH, Neugut AI (1998) Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol 16: 979\u2013985","journal-title":"J Clin Oncol"},{"key":"BF6601794_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1200\/JCO.1999.17.2.494","volume":"17","author":"VR Grann","year":"1999","unstructured":"Grann VR, Whang W, Jacobson JS, Heitjan DF, Antman KH, Neugut AI (1999a) Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2. J Clin Oncol 17: 494\u2013500","journal-title":"J Clin Oncol"},{"issue":"Abst","key":"BF6601794_CR18","first-page":"1123","volume":"38","author":"L Hartmann","year":"1997","unstructured":"Hartmann L, Jenkins R, Schaid D, Yang P (1997) Prophylactic mastectomy (PM): preliminary retrospective cohort analysis. Proc Am Assoc Cancer Res 38 (Abst): 1123","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF6601794_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"LC Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340: 77\u201384","journal-title":"N Engl J Med"},{"key":"BF6601794_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/bmj.322.7278.76","volume":"322","author":"MB Hatcher","year":"2001","unstructured":"Hatcher MB, Fallowfield L, A'Hern R (2001) The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaire and semi structured interviews. BMJ 322: 76\u201379","journal-title":"BMJ"},{"key":"BF6601794_CR21","volume-title":"Research Methods in Health: Investigating Health and Health Services","author":"IR Jones","year":"1997","unstructured":"Jones IR (1997) Costing health services: health economics. In: Bowling A (ed) Research Methods in Health: Investigating Health and Health Services. Philadelphia: Open University Press"},{"key":"BF6601794_CR22","unstructured":"Kind P, Hardman G, Macran S (1999) UK Population Norms for the EQ-5D: Discussion Paper 172. Centre For Health Economics, University of York, York"},{"key":"BF6601794_CR23","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1001\/jama.1993.03500150087033","volume":"269","author":"MC King","year":"1993","unstructured":"King MC, Rowell S, Love SM (1993) Inherited breast and ovarian cancers, what are the risks? What are the choices? JAMA 269: 1975\u20131980","journal-title":"JAMA"},{"key":"BF6601794_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","volume":"49","author":"SH Landis","year":"1999","unstructured":"Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics. CA Cancer J Clin 49: 8\u201331","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"BF6601794_CR25","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1200\/JCO.2003.09.052","volume":"21","author":"H Meijers-Heijboer","year":"2003","unstructured":"Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21 (9): 1675\u20131681","journal-title":"J Clin Oncol"},{"key":"BF6601794_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonnin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66\u201371","journal-title":"Science"},{"key":"BF6601794_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0272989X9401400107","volume":"14","author":"DK Miller","year":"1994","unstructured":"Miller DK, Homan SM (1994) Determining transition probabilities: confusion and suggestions. Med Decis Making 14: 52\u201358","journal-title":"Med Decis Making"},{"key":"BF6601794_CR28","volume-title":"Screening in Chronic Disease","author":"AS Morrison","year":"1992","unstructured":"Morrison AS (1992) Early detection: sensitivity and lead time. In: Morris AS (ed) Screening in Chronic Disease, (2nd edn). New York, Oxford: University Press"},{"key":"BF6601794_CR29","doi-asserted-by":"crossref","unstructured":"National Institute of Health Consensus Development Panel (1997) National Institute of Health Consensus Development Conference Statement: breast cancer screening for women aged 40\u201349, January 21\u201323 1997. J Natl Cancer Inst 89: 1015\u20131026","DOI":"10.1093\/jnci\/89.14.1015"},{"key":"BF6601794_CR30","unstructured":"National Statistics (2001) Mortality Statistics General: Review of the Registrar General on Deaths in England and Wales, 1999. London: The Stationary Office"},{"key":"BF6601794_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ng1096-188","volume":"14","author":"C Oddoux","year":"1996","unstructured":"Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Natl Genet 14: 188\u2013190","journal-title":"Natl Genet"},{"issue":"Suppl 1","key":"BF6601794_CR32","first-page":"46","volume":"80","author":"BAJ Ponder","year":"1999","unstructured":"Ponder BAJ (1999) Costs, benefits and limitations of genetic testing for cancer risk. Br J Cancer 80 (Suppl 1): 46\u201350","journal-title":"Br J Cancer"},{"key":"BF6601794_CR33","unstructured":"Priority Areas Cancer Team\/Genetics Sub-committee of the Scottish Cancer Coordinating and Advisory Committee (1998) Cancer Genetics Services in Scotland, Scottish Office"},{"key":"BF6601794_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DEC, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JLA, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in population series of 649 women with ovarian cancer. Am J Hum Genet 68: 700\u2013711","journal-title":"Am J Hum Genet"},{"key":"BF6601794_CR35","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJM199705153362022","volume":"336","author":"D Schrag","year":"1997","unstructured":"Schrag D, Kuntz KM, Garber JE, Weeks JE (1997) Decision analysis\u2013effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 336: 1465\u20131471","journal-title":"N Engl J Med"},{"issue":"21","key":"BF6601794_CR36","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1200\/JCO.2003.01.088","volume":"21","author":"MD Schwartz","year":"2003","unstructured":"Schwartz MD, Kaufman E, Peshkin BN, Isaacs C, Hughes C, De Marco T, Finch C, Lerman C (2003) Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1\/BRCA2 mutation testing. J Vlin Oncol 21 (21): 4034\u20134041","journal-title":"J Vlin Oncol"},{"key":"BF6601794_CR37","first-page":"486","volume":"60","author":"OM Serova","year":"1997","unstructured":"Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, Narod SA, Lynch HT, Lenoir GM (1997) Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes? Am J Hum Genet 60: 486\u2013495","journal-title":"Am J Hum Genet"},{"key":"BF6601794_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1155\/1999\/564893","volume":"15","author":"M Steel","year":"1999","unstructured":"Steel M, Smyth E, Vasen H, Eccles D, Evans G, Moller P, Hodgson S, Stoppa-Lyonnet D, Chang-Claude J, Caligo M, Morrison P, Haites N (1999) Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration project. Dis Markers 15: 125\u2013131","journal-title":"Dis Markers"},{"key":"BF6601794_CR39","first-page":"1021","volume":"60","author":"D Stoppa-Lyonnet","year":"1997","unstructured":"Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot L, Fourquet A, Salmon R, Clough K, Pouillart P, The ICBCG, Bonaiti-Pellie C, Thomas G (1997) BRCA1 sequence variations in 160 individuals referred to a breast\/ovarian family cancer clinic. Am J Hum Genet 60: 1021\u20131030","journal-title":"Am J Hum Genet"},{"key":"BF6601794_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/ng1095-198","volume":"11","author":"JP Struewing","year":"1995","unstructured":"Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Natl Genet 11: 198\u2013200","journal-title":"Natl Genet"},{"key":"BF6601794_CR41","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 amongst Ashkenazi Jews. N Engl J Med 336: 1401\u20131408","journal-title":"N Engl J Med"},{"key":"BF6601794_CR42","first-page":"15","volume":"2","author":"TO Tengs","year":"2000","unstructured":"Tengs TO, Berry DA (2000) The cost effectiveness of testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility gene. Dis Manage Clin Outcomes 2: 15\u201324","journal-title":"Dis Manage Clin Outcomes"},{"key":"BF6601794_CR43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/0272989X9801800402","volume":"18","author":"TO Tengs","year":"1998","unstructured":"Tengs TO, Winer EP, Paddock S, Aguilar-Chavez O, Berry, DA (1998) Testing for BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis. Med Decis Making 18: 365\u2013375","journal-title":"Med Decis Making"},{"key":"BF6601794_CR44","first-page":"1179","volume":"2","author":"P Tonin","year":"1996","unstructured":"Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Lynch HT, Lenoir GM, Narod SA, Garber JE (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 1996 2: 1179\u20131183","journal-title":"Nat Med 1996"},{"key":"BF6601794_CR45","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/bmj.319.7214.914","volume":"319","author":"DJ Torgerson","year":"1999","unstructured":"Torgerson DJ, Raftery J (1999) Economic notes: discounting. BMJ 319: 914\u2013915","journal-title":"BMJ"},{"key":"BF6601794_CR46","unstructured":"US Department of Health & Human Services (1999) Understanding Gene Testing \n                    http:\/\/www.accessexcellence.org\/AE\/AEPC\/NIH\/indcx.html"},{"key":"BF6601794_CR47","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jmg.34.9.741","volume":"34","author":"AAPM Van der Riet","year":"1997","unstructured":"Van der Riet AAPM, Van Hout BA, Rutten FFH (1997) Cost effectiveness of DNA diagnosis for monogenic diseases. J Med Genet 34: 741\u2013745","journal-title":"J Med Genet"},{"key":"BF6601794_CR48","first-page":"496","volume":"60","author":"AS Whittemore","year":"1997","unstructured":"Whittemore AS, Gong G, Itnyre J. (1997) Prevalence and contribution of BRCA1 mutation in breast cancer and ovarian cancer: results from three US population-based case\u2013control studies of ovarian cancer. Am J Hum Genet 60: 496\u2013504","journal-title":"Am J Hum Genet"},{"key":"BF6601794_CR49","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789\u2013792","journal-title":"Nature"},{"key":"BF6601794_CR50","first-page":"451","volume":"14","author":"LD Ziegeler","year":"1991","unstructured":"Ziegeler LD, Kroll SS (1991) Primary breast cancer after prophylactic mastectomy. Clinical case report from MD Anderson Cancer Centre. Clin Oncol 14: 451\u2013454","journal-title":"Clinical case report from MD Anderson Cancer Centre. Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601794","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:57:28Z","timestamp":1684414648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,20]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["BF6601794"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601794","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,20]]}}}